Faculty

Institution

Unit

Venue

Jeffrey J. Molldrem

Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

Department Of Immunology

The University of Texas MD Anderson Cancer Center

Jeffrey J. Molldrem is currently serving as a Hematopoietic Biology And Malignancy Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jeffrey J. Molldrem

The University of Texas MD Anderson Cancer Center

Professor

You can click a keyword to filter the displayed items

immunology hematology cell biology immune responses immunotherapy leukemia cellular therapy cell transplantation cancer immunotherapy medicine cancer cells bone marrow transplantation hematological malignancies cellular immune responses oncology tumor biology cell research clinical transplantation medicinal research stem cell transplantation cancer research cell therapy experimental medicine transplantation medicine regenerative medicine myeloid neoplasia dermatology immunomodulation cell death oncogenes antigen processing hla typing cancer treatment stem cell research adaptive immune system clinical immunology cancer biology graft rejection cancer immunosurveillance cord blood cancer care molecular cancer therapeutic vaccines acute myeloid leukemia t-regulatory cell malignant blood disorders lymphoid neoplasia graft survival tumor targeting molecular immunology adult t-cell leukemia-lymphoma myeloid leukemia stem-cell therapy vascular biology cancer management peptide therapeutics graft-versus-host disease thoracic oncology immunohaematology cancer genomics chronic myelogenous leukemia myelodysplastic syndrome myelodysplastic syndromes allogeneic transplantation healthy donors graft-versus-leukemia effect multiple myeloma cell culture aplastic anemia bone marrow failure cord blood transplantation antithymocyte globulin platelet engraftment hemorrhagic cystitis alloimmune responses nonmyeloablative preparative regimens laboratory investigation metastasis translational research biosystems infectious diseases computational biology pathology molecular informatics epigenetics translational medicine clinical proteomics nature method molecular diagnostics tumor microenvironment jama oncology bioinformatics forensic genetics individualized medicine omics biomarkers functional genomics biostatistics cancer letter biotechnology advance carcinogenesis biomedical informatics systems biology genetics cancer discovery personalized medicine mesothelioma histopathology molecular biology biomedical analysis molecular medicine

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4053: Nrp1 Drives a Novel Cross-Presentation Pathway Exploitable by Peptide-Linked Antibodies to Redirect Viral Memory T-Cells Against Solid Tumors. Cancer Research (2026)

immunological memorycancer immunotherapyimmune responsescellular therapypeptide-linked antibodiesantigen processingnovel cross-presentation pathwaycell biologycancer cellsimmunotherapyviral oncologyimmunologyantiviral responsesviral memory t-cellstherapeutic targetscellular immune responses

Abstract 4056: Preclinical Evaluation and Safety of Cbx-250 in Acute Myeloid Leukemia: A Bispecific T Cell Engager Targeting Cathepsin-G Peptide/Hla Complex. Cancer Research (2026)

hematologycancer immunotherapyimmune responsescellular therapyhematological malignanciescell biologyleukemiaimmunotherapymalignant blood disordersabstract 4056immunologytherapeutic targetsexperimental medicineacute myeloid leukemiacathepsin-g peptide/hla complex

Fecal Carbohydrate-Degrading Bacteria Are Associated With Reduced Incidence of Lower Gastrointestinal Gvhd. Blood Advances (2026)

pathogenic bacteriamicrobiologydigestive diseasesdysbiosisinfectious diseasesmicrobiomebacteriaclinical microbiologylower gastrointestinal gvhdreduced incidencemicrobial contaminationgut microbesenvironmental microbiologymicroorganismsfecal carbohydrate-degrading bacteriadigestive tract

1228 Immune Escape Through Oncogene-Mediated Editing of the Hla-Ligandome. Regular and Young Investigator Award Abstracts (2025)

immune responsesimmune escapeimmunologycell transplantationhla typing

1299 Tri-Specific T Cell Engager (Tce) Targeting Cathepsin G Peptide-Hla (Phla) Complex With Enhanced Antileukemic Activity via Proprietary Cd28 Co-Stimulation. Regular and Young Investigator Award Abstracts (2025)

immunomodulationautoimmune diseasescell biologyleukemiacell transplantationtherapeutic targetspeptide sciencecathepsin g peptide-hlaenhanced antileukemic activitycellular therapyimmunologic mechanismsantigen processingimmunotherapyproprietary cd28 co-stimulationpeptidescellular immune responsesimmune responsesimmunologyimmunity (medicine)medicinal researchexperimental medicine

2-Methoxyestradiol Treatment Prevents Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect in Mice. bioRxiv (Cold Spring Harbor Laboratory) (2025)

hematologymedicinehaematopoiesisgraft-versus-leukemia effectstem cellsbone marrow transplantationimmunologypharmacologycell transplantationcell replacement therapies

Anti-Gm-Csf Autoantibodies in Myeloid Leukemias. Best Practice & Research Clinical Haematology (2025)

A Phase I Study of the T-Cell Receptor-Like Antibody Hu8F4 in Pts With Advanced Myeloid Neoplasms. Blood (2025)

immunomodulationcancer immunotherapyimmune responsescellular therapycell therapycell biologycancer cellsleukemiaimmunotherapyadvanced myeloid neoplasmsimmunologycell researchcell transplantationexperimental medicine

Biophysical Modeling for Accurate T Cell Specificity Prediction of Viral and Tumor Antigens. bioRxiv (Cold Spring Harbor Laboratory) (2025)

immune responsesviral dynamicsquantitative biologyimmunologycomputational biologycell research

Copper Sulfide Nanoparticle–Mediated Photothermolysis Induces Immunogenic Cell Death in Ovarian Cancer Cells. bioRxiv (Cold Spring Harbor Laboratory) (2025)

nanoparticlesbiomolecular engineeringovarian cancer cellscell biologyovarian cancercancer cellsphototoxicitybiochemistrynanoparticle researchphotomedicinephotodynamic therapy

1
2
3
4
5
32
10 / page

Jeffrey J. Molldrem

Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

Department Of Immunology

The University of Texas MD Anderson Cancer Center

Jeffrey J. Molldrem is currently serving as a Hematopoietic Biology And Malignancy Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jeffrey J. Molldrem

The University of Texas MD Anderson Cancer Center

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4053: Nrp1 Drives a Novel Cross-Presentation Pathway Exploitable by Peptide-Linked Antibodies to Redirect Viral Memory T-Cells Against Solid Tumors. Cancer Research (2026)

Abstract 4056: Preclinical Evaluation and Safety of Cbx-250 in Acute Myeloid Leukemia: A Bispecific T Cell Engager Targeting Cathepsin-G Peptide/Hla Complex. Cancer Research (2026)

Fecal Carbohydrate-Degrading Bacteria Are Associated With Reduced Incidence of Lower Gastrointestinal Gvhd. Blood Advances (2026)

1228 Immune Escape Through Oncogene-Mediated Editing of the Hla-Ligandome. Regular and Young Investigator Award Abstracts (2025)

immune responsesimmune escapeimmunologycell transplantationhla typing

2-Methoxyestradiol Treatment Prevents Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect in Mice. bioRxiv (Cold Spring Harbor Laboratory) (2025)

hematologymedicinehaematopoiesisgraft-versus-leukemia effectstem cellsbone marrow transplantationimmunologypharmacologycell transplantationcell replacement therapies

Anti-Gm-Csf Autoantibodies in Myeloid Leukemias. Best Practice & Research Clinical Haematology (2025)

A Phase I Study of the T-Cell Receptor-Like Antibody Hu8F4 in Pts With Advanced Myeloid Neoplasms. Blood (2025)

Biophysical Modeling for Accurate T Cell Specificity Prediction of Viral and Tumor Antigens. bioRxiv (Cold Spring Harbor Laboratory) (2025)

immune responsesviral dynamicsquantitative biologyimmunologycomputational biologycell research

Copper Sulfide Nanoparticle–Mediated Photothermolysis Induces Immunogenic Cell Death in Ovarian Cancer Cells. bioRxiv (Cold Spring Harbor Laboratory) (2025)

nanoparticlesbiomolecular engineeringovarian cancer cellscell biologyovarian cancercancer cellsphototoxicitybiochemistrynanoparticle researchphotomedicinephotodynamic therapy

1
2
3
4
5
32
10 / page